pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,061 catalysts · 3,086 8k filing · 576 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage · 89 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 57 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-10×clear all
type
  • 8k filing3,086
  • earnings576
  • phase 2 completion172
  • grant138
  • drug shortage133
  • approval89
phase 1 completion
73
  • phase 2 initiation62
  • phase 1 initiation40
  • recall37
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 6, 2026

    40
    ›Apr 10, 2026device pma124d agoMicroTransponder, Inc. — Vivistim® System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QPY. Advisory committee: PM. Decision: OK30

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoBoston Scientific — • Lead Stylets, Straight, X-Soft Models 5003, 5004, 5005 • Lead Stylets, Long Tapered, Soft Models 5012, 5013, 5014 (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Real-Time Process. Product code: LWP. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoBoston Scientific — Straight Lead Stylets Limber Models 6033, 6034; Straight Lead Stylets Firm Models 6036, 6037; J Shaped Lead Stylets Limb (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoMedtronic — HEARTWARE VENTRICULAR ASSIST SYSTEM (PMA supplement)Medtronic plc

    Supplement type: Normal 180 Day Track. Product code: DSQ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoBoston Scientific — • ACUITY X4 Connector Tool Model 4625 • AICD Lead Stylets Firm Model 6971 • AICD Lead Stylets Soft Model 6972 • Suture S (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Real-Time Process. Product code: LWS. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoEdwards Lifesciences, LLC — Edwards EVOQUE Tricuspid Valve Replacement System (PMA supplement)Edwards Lifesciences Corp

    Supplement type: Special (Immediate Track). Product code: NPW. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoBoston Scientific — Fixation Tool Model 6616 (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Real-Time Process. Product code: NVN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoImpulse Dynamics (Usa), Inc. — GUARDIO/VESTA Charger (PMA supplement)

    Supplement type: Real-Time Process. Product code: QFV. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoOrganox Limited — OrganOx metra® System (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: QQK. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Apr 10, 2026device pma124d agoDepuy, Inc. — LCS® Total Knee System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NJL. Advisory committee: OR. Decision: OK30

    full page →fda device pma ↗
    ›Apr 10, 2026grant124d agoSTANFORD UNIVERSITY — Faster MRI through portable Resonance Gradient Coils with seamless calibratio...Stanford University

    EB grant. $217,500. PI: Kawin Setsompop

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF CINCINNATI — Mapping Activated Microglia and Their Effect on Cognitive Deficits in Adults ...

    HL grant. $186,613. PI: Kristine Karkoska

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoDARTMOUTH COLLEGE — Targeting Evasion Factors: Discovery of novel antibodies for durable suppress...

    AI grant. $215,758. PI: Margaret E Ackerman

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoINDIANA UNIVERSITY INDIANAPOLIS — A mouse model to analyze Foxp3+ TFH cells

    AI grant. $158,500. PI: Alexander L Dent

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Comparative vertebrate neural crest contribution to the hematopoietic stem ce...

    HL grant. $140,809. PI: Diana Sa Da Bandeira

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoOLD DOMINION UNIVERSITY — Mechanisms of Macrophage Manipulation by pathogenic SFG Rickettsia: Role of M...

    AI grant. $440,949. PI: Isaura Simoes

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoFLORIDA STATE UNIVERSITY — Cytosolic DNA sensing pathway regulation via non-canonical NF-kB signaling

    AI grant. $372,997. PI: Kislay Parvatiyar

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Identifying immune-mediated mechanisms of RAS inhibitor efficacy and resistan...

    CA grant. $384,630. PI: John Justin Milner

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Advancing Analytical Tools to Quantify and Mitigate the Risk for Transitionin...University of California San Francisco

    AI grant. $787,837. PI: Seth Blumberg

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoAMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY — 2026 Annual Meeting of the American Society for Investigative Pathology

    CA grant. $10,000. PI: WILLIAM B COLEMAN

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF CALIFORNIA SANTA BARBARA — Real-time, seconds-resolved measurements of amino acid homeostasis and its re...

    EB grant. $594,748. PI: Tod Edward Kippin

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF PENNSYLVANIA — Defining the determinants of long term CAR-T persistenceUniversity of Pennsylvania

    CA grant. $703,071. PI: Saar Gill

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Translational Research Program on PFAS and Metabolic Diseases: A Solution Ori...University of Southern California

    ES grant. $1,256,897. PI: VAIA LIDA CHATZI

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoBROWN UNIVERSITY — Discovery and Development of Novel Antimalarial Drugs

    AI grant. $791,611. PI: Jonathan D. Kurtis

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoSTANFORD UNIVERSITY — Development of 3D Multi-cellular Cardiac Tissues for Modeling Delayed Radiati...Stanford University

    AI grant. $538,838. PI: ADAM J CHICCO

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoBRIGHAM AND WOMEN'S HOSPITAL — Macrophage-directed strategies for BRCA-associated breast cancerBrigham and Women's Hospital

    CA grant. $772,208. PI: Jennifer L. Guerriero

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoCOLUMBIA UNIV NEW YORK MORNINGSIDE — Molecular and Functional Characterization of Cortical Circuits Regulating the...

    AT grant. $167,400. PI: Joshua Solomon Greene

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoMASSACHUSETTS GENERAL HOSPITAL — Comprehension and Perception of Genetic Influence: A Psychosocial Examination...Massachusetts General Hospital

    HG grant. $143,329. PI: Remy Furrer

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Mechanisms of respiratory viral infections in hospitalized children

    AI grant. $598,906. PI: Marc B. Hershenson

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF MINNESOTA — Technology Development for Whole Brain Functional and Structural Connectivity...University of Minnesota

    EB grant. $531,021. PI: Alireza Sadeghi Tarakameh

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF VIRGINIA — Microbial drivers of oral vaccine failureUniversity of Virginia

    AI grant. $242,250. PI: Carrie Adeline Cowardin

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — CARE: Community Action Research for Equity – Understanding care and decision ...University of California San Francisco

    NR grant. $758,207. PI: Jennifer E James

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Investigating Syndecan-1 in Hepcidin Regulation and Iron MetabolismUniversity of Utah

    DK grant. $198,431. PI: Philip Gordts

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF CHICAGO — Alcohol Stimulation and Sedation in Binge Drinkers

    AA grant. $699,952. PI: DANIEL J FRIDBERG

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF WISCONSIN-MADISON — Defining heterogeneity of stress-induced beta cell senescence programs in typ...

    DK grant. $757,946. PI: Sangeeta Dhawan

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF PENNSYLVANIA — Genomic and Clinical Mechanisms and Prognostic Implications of Myocardial Lip...University of Pennsylvania

    HL grant. $169,020. PI: Lingyu Xu

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoJOHNS HOPKINS UNIVERSITY — Defective HIV-1 proviral abundance and their immune effects in children and a...Johns Hopkins University

    AI grant. $779,616. PI: Deborah Persaud

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Biomarkers and Predictors of Treatment Response in Chronic Anemia in Sickle C...

    HL grant. $190,188. PI: JULIA Z XU

    full page →nih reporter ↗
    ›Apr 10, 2026grant124d agoUNIVERSITY OF NEW ENGLAND — A Prospective Study of Per-and Polyfluoroalkyl Substance (PFAS) Mixtures and ...

    ES grant. $163,856. PI: Samantha Schildroth

    full page →nih reporter ↗
    ›Apr 11, 2026grant123d agoSAINT LOUIS UNIVERSITY — Electrophilic Halogenated Fatty Aldehydes Target Erythrocytes to Mediate Halo...

    ES grant. $1,377,000. PI: DAVID A. FORD

    full page →nih reporter ↗

    Week of Apr 13, 2026

    10
    ›04/13/2026recall121d agoMorovan recall: Cosmetics

    Gel Nail Polish Remover (15ml)

    full page →fda recalls ↗
    ›Apr 13, 2026approval
    ← prev
    page 2 of 82
    next →
    121d ago
    OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Apr 13, 2026approval121d agoVANFLYTA (QUIZARTINIB DIHYDROCHLORIDE) — FDA approvalquizartinib dihydrochloride

    Sponsor: DAIICHI SANKYO INC. Form: TABLET. Route: ORAL

    full page →quizartinib dihydrochloride →fda approvals ↗
    ›Apr 13, 2026approval121d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 13, 2026approval121d agoLAMOTRIGINE — FDA approvalAlembic Pharmaceuticals Inc

    Sponsor: ALEMBIC PHARMS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 13, 2026approval121d agoLURASIDONE HYDROCHLORIDE — FDA approvalLURASIDONE HYDROCHLORIDE

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →LURASIDONE HYDROCHLORIDE →fda approvals ↗
    ›Apr 13, 2026approval121d agoLURASIDONE HYDROCHLORIDE — FDA approvalLURASIDONE HYDROCHLORIDE

    Sponsor: TORRENT. Form: TABLET. Route: ORAL

    full page →LURASIDONE HYDROCHLORIDE →fda approvals ↗
    ›Apr 13, 2026approval121d agoSPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Apr 13, 2026approval121d agoARTESUNATE — FDA approvalARTESUNATE

    Sponsor: AMIVAS. Form: POWDER. Route: INTRAVENOUS

    full page →ARTESUNATE →fda approvals ↗
    ›Apr 13, 2026approval121d agoPIMOZIDE — FDA approvalPIMOZIDE

    Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

    full page →PIMOZIDE →fda approvals ↗
    $BSX50.46+2.33%
    $BSX50.46+2.33%
    $EW91.33-2.47%
    $BSX50.46+2.33%
    $MDT89.41+2.58%
    $BSX50.46+2.33%